Connection

Rose Kenny to Alzheimer Disease

Back to Details
This is a "connection" page, showing publications Rose Kenny has written about Alzheimer Disease.
Rose Kenny
Connection Strength
0.170
Alzheimer Disease
  1. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial. PLoS Med. 2018 09; 15(9):e1002660.
    View in: PubMed
    Score: 0.090
  2. Clinical Consensus Guidelines on the Application of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: Recommendations of the Irish Network for Biomarkers in Neurodegeneration. Ir Med J. 2016 Dec 12; 109(10):483.
    View in: PubMed
    Score: 0.080
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.